Significant changes have occurred in the clinical characteristics, management strategies and outcomes of ST-segment elevation myocardial infarction (STEMI) patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection during the course of the pandemic, according to new results from the North American COVID-19 STEMI (NACMI) registry.